Robert R Bies (Robert Bies)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Clinical pharmacology and therapeutics

CPT: pharmacometrics & systems pharmacology

Journal of pharmacokinetics and pharmacodynamics

The Prostate

Georgetown University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Georgetown University Aug 15 1994 - Dec 31 1998

United States

PHD :: Pharmacology

University of Toronto Sep 01 1987 - Jun 01 1991

Canada

BSC :: School of Pharmacy

Publications

Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics 115 (5) (2024)
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics (2024)
Christos Kaikousidis, Robert R Bies, Aristides Dokoumetzidis
Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability. CPT: pharmacometrics & systems pharmacology (2024)
Xinnong Li, Mark Sale, Keith Nieforth, James Craig, Fenggong Wang, David Solit, Kairui Feng, Meng Hu, Robert R Bies, Liang Zhao
pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization. Journal of pharmacokinetics and pharmacodynamics (2024)
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics 115 (5) (2024)
Ming-Liang Tan, Sajeev Chandran, Rebeka Jereb, Khondoker Alam, Robert R Bies, Darby Kozak, Ross Walenga, Maxime Le Merdy, Andrew Babiskin
Mechanistic modeling of ophthalmic, nasal, injectable, and implant generic drug products: A workshop summary report. CPT: pharmacometrics & systems pharmacology (2023)
Xinnong Li, Mark Sale, Keith Nieforth, Kristin L Bigos, James Craig, Fenggong Wang, Kairui Feng, Meng Hu, Robert R Bies, Liang Zhao
pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed-effect Model Selection Toolbox. Clinical pharmacology and therapeutics (2023)
Ming-Liang Tan, Sajeev Chandran, Rebeka Jereb, Khondoker Alam, Robert R Bies, Darby Kozak, Ross Walenga, Maxime Le Merdy, Andrew Babiskin
Mechanistic Modeling of Ophthalmic, Nasal, Injectable, and Implant Generic Drug Products: A Workshop Summary Report. CPT: pharmacometrics & systems pharmacology (2023)
Jagdeep T Podichetty, Rebecca M Silvola, Violeta Rodriguez-Romero, Richard F Bergstrom, Majid Vakilynejad, Robert R Bies, Robert E Stratford
Application of machine learning to predict reduction in total PANSS score and enrich enrollment in schizophrenia clinical trials. Clinical and translational science 14 (5) (2021)
Mason McComb, Robert R Bies, Murali Ramanathan
Machine learning in pharmacometrics: Opportunities and challenges. British journal of clinical pharmacology (2021)
Mohamed Ismail, Mark Sale, Yifan Yu, Nikhil Pillai, Sihang Liu, Beth Pflug, Robert R Bies
Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection. Journal of pharmacokinetics and pharmacodynamics (2021)
Andreas Krause, Charlotte Kloft, Wilhelm Huisinga, Mats O Karlson, José Pinheiro, Robert R Bies, James Rogers, France Mentré, Bret J Musser, null null
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873. Pharmaceutical statistics 18 (3) (2019)
Robert R Bies
Preface to Special Issue for Panos Macheras. Journal of pharmacokinetics and pharmacodynamics 46 (2) (2019)
Sarah F Cook, Michael V Fiandalo, David S Watt, Yue Wu, James L Mohler, Robert R Bies
Mathematical modeling of intracrine androgen metabolism in prostate cancer: Methodological aspects. The Prostate (2018)

Robert R Bies.css-eqlu8i{font-size:small;padding-left:4px;} (Robert Bies)

Publication Activity (10 Years)

Top Topics

Top Venues

Robert R Bies (Robert Bies)